Cryptococcus neoformans is a major cause of systemic fungal infection in immunocompromised patients. Myristoyl-CoA:protein N-myristoyltransferase (Nmt) catalyzes the transfer of myristate (C14:0) from myristoyl-CoA to the N-terminal glycine of a subset of cellular proteins produced during vegetative growth of C. neoformans. A Glyw --Asp mutation was introduced into C. neoformans NMT by targeted gene replacement. The resulting strains are temperaturesensitive myristic acid auxotrophs. They are killed at 37C when placed in medium lacking myristate and, in an immunosuppressed animal model ofcryptococcal meningitis, are completely eliminated from the subarachnoid space within 12 days of initial infection. C. neoformans and human Nmts exhibit differences in their peptide substrate specificities. These differences can be exploited to develop a new class of fungicidal drugs.
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Cryptococcus neoformans var. neoformans is an opportunistic pathogen which has emerged as a serious cause of systemic fungal infection in immunocompromised humans (1) (2) (3) . Persistent C. neoformans infections are common in AIDS patients after completion of primary therapy with amphotericin B or fluconazole for meningitis. This leads to relapse rates of 50-60%o and a shortened lifespan unless patients receive lifelong suppressive therapy, generally with fluconazole (4, 5) . Both amphotericin B and fluconazole target ergosterol, the principal sterol in the organism's plasma membrane. Amphotericin B, a fungicidal macrolide, also binds to cholesterol in animal cell membranes, resulting in renal and other toxicities. Chronic suppressive therapy with the fungistatic drug fluconazole in severely immunocompromised hosts will most likely result in emergence of resistant strains (6) . The search for alternative therapeutic targets in this organism would be helped by the ability to use targeted gene disruption to establish whether a given gene product is essential for viability. Protocols for high-efficiency transformation of C. neoformans have been reported (7) (8) (9) . Gene replacement has remained elusive and may be strain-or locus-specific (9, 10) .
Myristoyl-CoA:protein N-myristoyltransferase (Nmt) catalyzes the cotranslational transfer of myristate (C14:0) from myristoyl-CoA to the amino-terminal glycine of a subset of eukaryotic cellular and viral proteins (11) . Saccharomyces cerevisiae and human Nmts have an ordered bi-bi reaction mechanism: the apoenzymes bind to myristoyl-CoA, forming a high-affinity binary complex. Formation of this complex allows generation of a functional peptide binding site and subsequent generation of a myristoyl-CoA/Nmt/peptide ternary complex. After catalysis, CoA and then the myristoylpeptide product are released (12) (13) (14) .
NMTgenes have been isolated from S. cerevisiae, Candida albicans, Histoplasma capsulatum, C. neoformans, and humans (15) (16) (17) (18) . All are present in a single copy per haploid genome. Several S. cerevisiae N-myristoylproteins are essential for viability and depend upon a covalently bound myristoyl group for expression of their biological functions. These include two ADP-ribosylation factors, Arfip and Arf2p, which modulate several steps in vesicular/protein transport (19) , and Gpalp, the a subunit (G.) of the heterotrimeric guanine nucleotide-binding protein involved in mating-factor signal transduction (20) . Disruption of NMT1 in S. cerevisiae causes recessive lethality (15) . Metabolic labeling studies indicate that C. neoformans produces several cellular N-myristoylproteins during exponential growth (21) . Two have been identified: an Arf (17) and a Ga homolog (22) . C. neoformans NMT can complement the lethal phenotype of a S. cerevisiae nmt null allele (17) .
We have used targeted gene replacement to establish that Nmt is an essential enzyme in C. neoformans. Moreover, sufficient differences exist in the peptide substrate specificities of the orthologous fungal and human enzymes to make Nmt an attractive target for development offungicidal agents.
MATERIALS AND METHODS
Replacement of C. neoformans NMT with nmt487D. M049 is a serotype A ade2 strain of C. neoformans (9) . Southern blot analysis indicated that M049's single-copy NMT gene is contained in a 6.2-kb HindIII fragment. A size-selected HindIII genomic library was generated from strain M049 and screened with a full-length Nmt cDNA (17) to recover NMT.
A Gly -* Asp mutation was subsequently engineered at codon 487 by using PCR and 5'-AACAAGGATCCAA-GATCGACGTCGTCATG-3' as the coding-strand mutagenic primer. An nmt487D-ADE2 plasmid (pCN28-14; Fig. 1A ) was constructed by ligating (i) the =4.5-kb HindIII-Nco I fragment containing nmt487D, (ii) a 3.0-kb ADE2 fragment from pCnade2A&Apa (9) , and (iii) an =2.4-kb BamHI-HindIII fragment containing 3' NMT flanking sequence into pCRII (Invitrogen). pCN28-14 was partially digested with HindIII, resulting in a mixture of DNAs which was used for projectilemediated transformation of M049.
M049 was prepared for transformation by inoculating 50 ml of yeast extract/peptone/dextrose (YPD) medium with two or three colonies and vigorously shaking the culture for 48 hr. The late-logarithmic-phase cells were pelleted at 1000 x g and suspended in 17 ml of regeneration medium ( 9 ) plus pCN25-28 and pCN28-14 DNA (100 pg). The blot was probed with a 32P-labeled, 6.2-kb HindIII fragment from pCN25-28. In CMD4, the 6.2-kb endogenous NMT HinduI fragment is absent. The 6.0-, 5.5-, and 2.4-kb EcoRI fragments in CMD2 and CMD4 DNA comigrate with EcoRI fragments from pCN28-14. The 3.0-kb EcoRI fragment contains sequences from the extreme 5' end of the NMT allele. The presence of extra HindIll and EcoRI bands in CMD2 and CMD4 suggested that portions of pCN28-14 had been integrated into more than one site. Digestion with Nru I, which does not cleave the 6.2-kb NMT fragment or the 3.0-kb ADE2 fragment, established that there were two integration sites in CMD4. One site was at the NMTlocus and contained a single copy of the mutant allele without associated vector sequences. There was one other extragenic site of integration that did contain vector sequences. Phosphorlmager (Molecular Dynamics) scans of Southern blots disclosed that CMD2 contained 10 copies of the mutant allele at the NMT1 locus (data not shown). (C) Allele-specific PCR. (Upper) One hundred picograms of plasmid DNAs, 1 pg of genomic DNA, or 1 pig genomic DNA plus 100 pg of plasmid DNA were used as the templates in PCRs with an nmt487D-specific coding-strand primer plus a noncoding-strand primer. (Lower) The same DNAs were used as templates in PCRs with an NMT-speciflc noncoding-strand primer and a coding-strand primer.
glucose/500 juM myristate/0.5% Brij/2% agar). DNA was precipitated onto gold beads by adding (in order with continuous vortexing) 3 of a 1-pug/ml solution of DNA, 30 p. of 2.5 M CaCl2, and 6 A4 of 1 M,spermidine (free base) to 30 Ad of gold beads (1 pm; Bio-Rad; 60 mg/ml of water). The beads were washed in ethanol and spread on macrocarriers (Bio-Rad; -10 Al of DNA-coated beads/macrocarrier). The macrocarriers were subsequently dried in a dessicator box and placed in a Bio-Rad Biolistic PDS-1000 particle delivery system, where they were subjected to 1300 psi (1 psi = 6.89 kPa) to deliver the DNA-coated beads to the plates of C. neoformans M049. After incubation at 240C for 5-6 days, transformants were screened by (i) incubation at 370C on plates of synthetic medium which lacked adenine and (ii) incubation at 240C on synthetic medium which lacked adenine but contained 500 ,uM myristate.
NMT Aflele-Specific PCR. PCR mixtures contained genomic DNA (1 IHg), a mutant-specific coding-strand primer (5'-CCAAACAAGGATCCAAGATCGA-3', where the 3' A of the primer is the mutated nucleotide in codon 487), a noncoding-strand primer (5'-CACGGCTCGAGCGGCCG-CAAAATATGCATGTCATAG-3'), 2.5 mM MgCl2, and 1 unit of AmpliTaq DNA polymerase (Cetus). The wild-type NMT allele was identified with a noncoding-strand primer (5'-GGATTTTAGAGCATGACGACGC-3'), a codingstrand primer (5'-AAAGTTCGGACCAGGCGATG-3'), and 1 mM MgCl2. Thermocycling conditions were 940C for 1 min, 650C for 1 min, and 720C for 1 min for 25 cycles.
Purification of Human and C. neoformans Nmts from Escherichia coil. Human Nmt was expressed in E. coli and purified to apparent homogeneity as described (23) . C. neoformans Nmt was also expressed in and purified from E. coli. An amino-terminal tag of six histidine residues followed by a factor Xa cleavage site (IEGR) was engineered by PCR using 5' -GCCCATGGCACACCATCACCATCACCATATC-GAAGGTCGCGATTCCTCTGATAACAAGGCC-3' as the mutagenic primer and pCN1-18 (17) (17) . Gly451 Asp substitution in S.
cerevisiae Nmtlp produces a temperature-dependent reduction in the enzyme's affinity for myristoyl-CoA (24 cerevisiae Nmtlp. C. neoformans Nmt containing a genetically engineered Gly487 -* Asp mutation exhibits temperature-dependent reductions in its activity when coexpressed with C. neoformans Arf in E. coli, a bacterium with no endogenous Nmt (17). C. neoformans nmt487D also produces temperature-sensitive growth arrest and myristate auxotrophy when used to complement a S. cerevisiae nmtlA allele (17) .
The coding sequences of C. neoformans genes can vary by up to 5% between different strains, particularly those with different serotypes (26) . The NMT allele used for mutagenesis and targeted gene disruption was recovered from a serotype A recipient strain (M049; ref. 9). ADE2 (9), used as a selectable marker in the disruption vector, was recovered from a serotype D strain (B-3501; ref. 9) . We reasoned that these choices should reduce the likelihood of recombination at M049's ade2 allele and increase the likelihood of recombination at its NMT locus.
Southern blots of M049 genomic DNA indicated that the entire -2.5-kb NMT locus was contained in a 6.2-kb HindIII DNA fragment. This locus was recovered from a sizeselected HindIII M049 genomic library (Fig. 1A) . A Gly487-_ Asp mutation was engineered by PCR. The nmt487D allele was then fused to a 3-kb restriction fragment containing the C. neoformans ADE2 gene (9) linked to 2 kb from the 3' flanking region of NMT (pCN28-14; Fig. 1A ). pCN28-14 was partially digested with HindIII and this mixture of DNAs was used to transform C. neoformans M049 with a particle delivery system (9) . When the recipient cells were plated on synthetic medium lacking adenine but supplemented with 500 ,uM myristate, 187 transformants (adenine prototrophs) were obtained. Six ADE transformants (=3%) were temperaturesensitive myristic acid auxotrophs, although with two distinct phenotypes, represented by isolates CMD2 and CMD4. CMD2 was the only transformant of the 6 that could grow in the presence of myristate at 37°C. CMD4, representative of the other 4 transformants, was unable to grow at 37°C and required myristate even at 24°C (Fig. 2) .
Southern blot analysis of uncut genomic DNA prepared from CMD2 and CMD4 indicated that all of the transforming DNA had been integrated into the hosts' chromosomes (data not shown). The blots revealed (Fig. 1B) 5.9-and 4.1-kb HindIII fragments, corresponding to the nmt487D allele, in both CMD2 and CMD4. PCR confirmed that only the mutant nmt487D allele was present in CMD2 and CMD4 (Fig. 1C) suited for homologous recombination with NMT. There were only modest differences in the fraction of transformants (adenine prototrophs) that were temperature-sensitive myristic acid auxotrophs: (i) 4/63 (6.3% yield) with the purified 10-kb (HindIII) nmt487D-ADE2-NMT3' fragment, (ii) 4/118 (3.4%) with the (HindIII) linearized recombinant plasmid, and (iii) 3/120 (2.5%) with supercoiled DNA. These results indicate that homologous recombination is reasonably efficient at this locus in the recipient serotype A strain. Phenotypic Analysis of Isogenic NMT and nmt487D Strains. C. neoformans isolate CMD2 (nmt487D) is viable at 24TC on YPD medium. Growth at 37TC requires supplementation with myristate. Palmitate (C16:0) at 500 ,AM not only fails to rescue viability at the nonpermissive temperature (37TC) but also suppresses growth at 24TC. The parental strain, M049, is able to grow at both temperatures in the absence or presence of myristate or palmitate. These growth characteristics mimic those seen with the corresponding S. cerevisiae NMT1 and nmtl-181 strains (Fig. 2) .
The CMD2 genome contains 10 copies of nmt487D (Fig.  1B) . CMD4 contains 2 copies of nmt487D and is unable to grow on YPD at 24°C without myristate (Fig. 2) . The phenotypic differences between CMD2 and CMD4 are most likely explained by a gene dosage effect, since overexpression of nmtl81p rescues S. cerevisiae nmtl-181 strains.
When grown at nonpermissive temperatures, S. cerevisiae nmtl-181 strains require that their intracellular myristoylCoA pools be maintained by contributions from at least two metabolic pathways: (i) de novo production by the fatty acid synthetase (Fas) complex and (ii) activation of imported myristate by two of the organism's four known long-chain acyl-CoA synthetases, Faalp and Faa4p (27) . Cerulenin is a specific inhibitor of Fas. It blocks growth of nmtl-181 (and NMTJ) strains. Growth can be restored by adding myristate to YPD/cerulenin medium (Fig. 2) . Isogenic NMT and nmt487D strains of C. neoformans are also unable to grow on YPD/cerulenin at 24°C or 37°C. Unlike S. cerevisiae NMT and nmtl-181 cells, the corresponding C. neoformans strains cannot be rescued on YPD/cerulenin by 500 ,uM myristate (Fig. 2) . These results suggest potential differences in the regulation of protein N-myristoylation and/or fatty acid utilization between S. cerevisiae and C. neoformans. The (Fig. 4) . Several of these peptides were excellent substrates for human Nmt but very poor substrates for C. neoformans Nmt: e.g., GNIFGNLL-amide (residues 1-8 of human ARF3) and GNAAAARR-amide (a derivative of the catalytic subunit of bovine protein kinase A). The two Nmts had no significant differences in their specific activities when incubated with GCTVSTQT-amide (from S. cerevisiae Gpalp) and GNIFANLF-amide (from human ARFM). Six neoformans Arf, the C. neoformans G, homolog, and orthologous fungal Arfs. Analysis of the CoA derivatives of C8:0 to C16:0 fatty acids, plus a series of myristic acid analogs with single triple bonds (2-to 13-tetradecynoyl-CoAs) and single cis double bonds (Z2-to Z12-tetradecenoyl-CoAs), using radiolabeled GA-RASVLS-amide as the peptide acceptor, indicated that human and C. neoformans Nmts have similar acyl-CoA binding sites: i.e., (i) they prefer myristoyl-CoA, although they can readily accommodate a one-methylene variation in acyl chain length; (ii) palmitoyl-CoA is not a substrate for either enzyme; and (iii) there is a principal bend at C5-C6 ofthe bound hydrocarbon which prevents 5-tetradecynoyl-CoA from forming a binary complex with these Nmts (31) . Together, these results suggest that it may be possible to design specific competitive inhibitors of C. neoformans Nmt which react with its peptide binding site and are fungicidal. 
